Authors: Nasiri A, Alahmadi A, Alshammari M, Alabiri R, Samarkandi S, Alfattah H, Alqahtani R, Alzahrani T, Samarkandi H, Habash A, Alsolamy E, Al Ghethber H, Alkharras R, Makhdoum G, Saleh MFM, Hanbali A, El Fakih R, Alzahrani H, Alahmari A, Aljurf M.
DOI: 10.46989/001c.150393
Abstract Summary
Ramadan fasting poses unique challenges for patients with blood disorders. While healthy individuals tolerate fasting safely, the 13-18 hour period of reduced hydration and nutrition can risk complications in those with anemia, clotting disorders, or blood cancers. High-risk patientsโincluding those on intensive chemotherapy or with severe anemiaโshould avoid fasting. However, stable patients may fast safely with careful medical evaluation, adjusted medication schedules, and strict hydration plans. Individualized risk assessment and shared decision-making between doctors and patients are essential until more evidence-based guidelines emerge.
Why Brain? ๐ง
Ramadan fasting poses risks for blood disorder patients through dehydration and nutritional changes. High-risk patients should avoid fasting, while stable patients may fast safely with careful monitoring and individualized plans.
Study Limitations:
Study limitations were not specified in the abstract.
License: cc by.
The image is AI-generated for illustrative purposes only. Courtesy of Midjourney.
